#Commercialization depends more than ever on specialized technologies and skilled workmanship, inducing an arduous search throughout the kingdom of #drugdevelopment and #manufacturing for #CDMO. “What #biopharma clients specifically ask us to provide them is our ‘preferred list of manufacturing contractors’ that fit their criteria,” says Kenton Shultis, CEO of Rondaxe Pharma. The search goes on ... #pharmaceuticalindustry #biotech https://lnkd.in/e242Hzat
Rondaxe Pharma
Pharmaceutical Manufacturing
Syracuse, NY 1,697 followers
A trusted solution provider for all aspects of Drug Development.
About us
Rondaxe is a drug development services company that strives to take innovative ideas from value creation to value realization. Recognizing the challenges and complexities of drug development in the disciplines covered by “Chemistry, Manufacturing and Controls”, we offer critical expertise, service and software solutions to our customers. Our goal is to effectively help emerging pharmaceutical and biotechnology companies navigate through all phases of the drug development and commercialization process. Customers can choose from our full suite of services and products, or select a specific offering at any point along the drug development timeline. Our philosophy is to be strategic, flexible, hands on and to design a solution based on a customer’s exact set of needs. Rondaxe is the first company to provide a suite of services that combines expert drug development consulting, in-depth project management leadership and software applications designed specifically for emerging pharma/biotechs. Rondaxe is led by four managing members, a team of experienced industry executives and 35 senior advisors, most of whom have 15-35+ years of industry experience, with a vision and an unflinching dedication to our clients’ success. Since our founding in 2003, we have had steady growth because of our proven track record in delivering results, establishing solid relationships with our customers, and a strong commitment to expand our skills and product offerings as our customer’s needs expand.
- Website
-
http://www.rondaxe.com
External link for Rondaxe Pharma
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Syracuse, NY
- Type
- Privately Held
- Founded
- 2003
- Specialties
- CMC Service & Consulting, Quality & Regulatory Service & Consulting, Virtual Business Development, and Software
Locations
-
Primary
6443 Ridings Road
Suite 125
Syracuse, NY 13206, US
-
14 Corporate Drive
Albany, NY 12065, US
Employees at Rondaxe Pharma
Updates
-
https://zurl.co/Ydr2C Merck just invested in a large Dutch organoid facility, enhancing their ability to test new drugs without using animals.
Merck KGaA’s MilliporeSigma absorbs Dutch organoid maker HUB Organoids
fiercebiotech.com
-
https://zurl.co/5K1EL AI is taking a new direction and is about to change the way we think about science and business.
Alphabet spinoff SandboxAQ raises $300M fund for ‘next wave of AI’
fiercebiotech.com
-
https://zurl.co/RFLRC ACG is expanding its capacity for printed tablets with a massive new facility in Thailand.
India's ACG kicks off operations at mammoth capsule plant in Thailand
fiercepharma.com
-
https://zurl.co/HQmX5 Roche is brining mass spectrometry to the everyday clinic - amazing.
Roche to bring mass spec to routine labs with new cobas system’s European approval
fiercebiotech.com
-
https://zurl.co/ha1n6 We finally have a vaccine specifically for the new bird flu, should it grow in proportions.
mRNA vaccine from CDC and Moderna protects ferrets from current avian influenza strain
fiercebiotech.com
-
https://zurl.co/u2Jq8 Congrats to BioAge on landing this impressive deal.
Novartis, BioAge take on age-related diseases in $550M pact
fiercebiotech.com
-
https://zurl.co/rv5AD Tavapadon brings a unique mechanism of action to the Parkinson's front; will it succeed on the market, though?
AbbVie's tavapadon achieves positive topline results in Phase III TEMPO-2 trial
clinicaltrialsarena.com
-
https://zurl.co/bofHq Everyone has to have an obesity pill these days.
Merck Joins Obesity Pill Race With Up to $2B Hansoh Deal
biospace.com
-
https://zurl.co/oMVwG Another deal aimed at broadening Novo's cardiometabolic portfolio beyond GLP-1s.
Novo Nordisk taps Photys for $186M cardiometabolic collab
fiercebiotech.com